Jian Kong
- Molecular Biology
- Cancer Research top 5%
- Hepatology top 2%
- Oncology
- Epidemiology
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (14 papers)Cancer, Hypoxia, and Metabolism (10 papers)Angiogenesis and VEGF in Cancer (6 papers)
- Partner nations
- ChinaUnited StatesRomania
In The Last Decade
Jian Kong
35 papers receiving 1000 citations
Peers
Comparison fields: 5 of 86
- Molecular Biology 433
- Cancer Research 345
- Hepatology 324
- Oncology 175
- Epidemiology 174
Countries citing papers authored by Jian Kong
This map shows the geographic impact of Jian Kong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jian Kong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jian Kong more than expected).
Fields of papers citing papers by Jian Kong
This network shows the impact of papers produced by Jian Kong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jian Kong. The network helps show where Jian Kong may publish in the future.
Co-authorship network of co-authors of Jian Kong
This figure shows the co-authorship network connecting the top 25 collaborators of Jian Kong. A scholar is included among the top collaborators of Jian Kong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jian Kong. Jian Kong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 81 | |
| 3 | 4 | |
| 4 | 5 | |
| 5 | 13 | |
| 6 | 26 | |
| 7 | 28 | |
| 8 | 19 | |
| 9 | 8 | |
| 10 | 43 | |
| 11 | 44 | |
| 12 | 18 | |
| 13 | 36 | |
| 14 | 2 | |
| 15 | 21 | |
| 16 | 38 | |
| 17 | 69 | |
| 18 | 14 | |
| 19 | 42 | |
| 20 | 113 |
About Jian Kong
Jian Kong is a scholar working on Hepatology, Cancer Research and Molecular Biology, having authored 37 papers that have together received 1.0k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (14 papers), Cancer, Hypoxia, and Metabolism (10 papers) and Angiogenesis and VEGF in Cancer (6 papers). The work is most often cited by research in Hepatology (324 citations), Cancer Research (345 citations) and Cell Biology (131 citations). Jian Kong has collaborated with scholars based in China, United States and Romania. Frequent co-authors include Lemin Zheng, Wenbing Sun, Shan Ke, Shuying Dong, Jun Gao, Xuemei Ding, Jinge Kong, Shaohong Wang, Bing Pan and Hui‐Chuan Sun. Their work appears in journals such as PLoS ONE, Clinical Cancer Research and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.